FT003 - End to End with Circular RNA

FT003 - End to End with Circular RNA

RNA therapeutics are programmable medicines: their sequence encodes their biological function. Yet RNA is not purely a store of digital information. It is also a physical molecule that needs to be packaged and delivered to patients. By circularizing RNA, we can stabilize the physical molecule while preserving the therapeutic information it encodes. Ginkgo offers a range of assets and capabilities to support our partners in developing RNA therapeutics for the circular format.

Posted by Jake Wintermute